Table 3. Characteristics of in-hospital survivors and non-survivors on the day of admission to intensive care unit.
| Survivors (N=303) | Non-survivors (N=332) | P | |
|---|---|---|---|
| Sodium (mmol/l) | 140 (104–178) | 137 (107–172) | 0.003 |
| Potasium (mmol/l) | 4.1 (2.3–8.7) | 4.2 (1.7–7.2) | 0.419 |
| Creatinine (μmol/l) | 78 (35–2759) | 126 (21–1252) | <0.0005 |
| Urea (μmol/l) | 8.1 (0.2–72) | 11.9 (0.6–52.5) | <0.0005 |
| Bilirubin (μmol/l) | 52 (5–667) | 125 (2–1058) | <0.0005 |
| Albumin (g/l) | 26 (8–58) | 27 (6–53) | 0.298 |
| White blood cells (×109/l) | 8.54 (0.84–64.37) | 11.2 (1.3–52) | <0.0005 |
| Platelets (×109/l) | 77 (11–824) | 73 (8–371) | 0.053 |
| INR | 1.8 (0.8–8) | 2.3 (1.09–10.2) | <0.0005 |
| Lactate (mmol/l) | 1.7 (0.14–18.3) | 3.28 (0.19–22.7) | <0.0005 |
| pH | 7.4 (7.1–7.59) | 7.36 (6.46–7.64) | <0.0005 |
| PaO2 (kPA) | 14.2 (3.49–59.76) | 13.19 (2.4–63.5) | 0.029 |
| PaCO2 (kPA) | 4.7 (2.74–8.8) | 4.8 (1.14–20.5) | 0.202 |
| FiO2 | 0.5 (0.1–1) | 0.6 (0.1–1) | <0.0005 |
| PaO2/FiO2 | 227 (44–910) | 187 (18–790) | <0.0005 |
| A-a gradient | 186 (−336 to 617) | 243 (−58 to 619) | <0.0005 |
| SOFA | 8 (0–31) | 12 (2–21) | <0.0005 |
| MELD | 18 (6–40) | 26 (9–40) | <0.0005 |
| MELD-sodium | 18.9 (1–74) | 28 (4–82) | <0.0005 |
| Child-Pugh score | 11 (5–15) | 12 (7–15) | <0.0005 |
| Child-Pugh class (%) | <0.0005 | ||
| A | 5 (2.2) | (0) | |
| B | 67 (29.6) | 24 (9) | |
| C | 154 (68.1) | 244 (91) | |
| APACHE II | 14 (0–31) | 19 (6–44) | <0.0005 |
A-a gradient, alveolar-arterial partial pressure oxygen gradient; APACHE, Acute Physiology and Chronic Health Evaluation; INR, international normalized ratio; MELD, Model for End-stage Liver Disease; SOFA, Sequential Organ Failure Assessment.
All values expressed as median (range).